Fondo Italiano di Investimento recently made a €15m investment in Sofinnova Capital VII.
Sofinnova Capital VII is the seventh venture capital fund launched by Sofinnova Partners. With a final close of €240m (read here), the focuses on backing companies operating in the life sciences (biopharma, biotech and medical devices).
The investment from Fondo Italiano di Investimento will enable the fund to dedicate a meaningful portion of the fund to back Italian startups.
Sofinnova Capital VII was also supported by European Investment Fund, Skandia Life Insurance Company, CNP Assurances and CDC Entreprises.